ROYALTY PHARMA

Acquisition and merger consultation, namely, identifying and acquiring revenue streams and monetization opportunities from the sale of biopharmaceutical products, pharmaceuticals, and medical diagnostics, devices, and equipment

Financial services, namely, capital and fund investment services; investment management and investment advisory services; identifying and acquiring revenue streams and monetization opportunities from the sale of biopharmaceutical products, pharmaceuticals, and medical diagnostics, devices, and equipment, namely, financial analysis in the nature of financial modelling of the future value of biopharmaceutical royalties and complex structured financing